Thomas Kuehr

Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly et al. · Journal of Clinical Oncology · 2022 · 120 citations · Full text

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

Kathleen M. Mullane, Vicki A. Morrison, Luis H. Camacho et al. · The Lancet Infectious Diseases · 2019 · 35 citations

Vaccination, Vaccine Safety, Vaccine Development +6

Immunogenetic analysis of spontaneous autoimmune thyroiditis of obese strain chickens

Guido Kroemer, Nikolaus Neu, Thomas Kuehr et al. · Clinical Immunology and Immunopathology · 1989 · 30 citations

Immunogenetics, Autoimmune Disease, Spontaneous Autoimmune Thyroiditis +10

Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study

Heinz Ludwig, Elisabeth Rauch, Thomas Kuehr et al. · Haematologica · 2014 · 28 citations · Full text

Renal Pathology, Phase Ii Study, Dialysis Therapy +17

A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha‐2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)—AGMT_CML 1

Sonja Heibl, Veronika Buxhofer‐Ausch, Stefan Schmidt et al. · Hematological Oncology · 2020 · 11 citations